Clinical trial for Mild Dementia
Official title SHARE Adaptation Intervention for African-American Families
ClinicalTrials.gov ID: NCT07208162
What this study is testing
- What it's testing
- This study is testing whether a culturally adapted SHARE program helps people with mild or moderate dementia and their care partners.
- Who it's for
- You may be able to join if you are African‑American, have mild or moderate dementia, and have a care partner.
- What's involved
- You would take part in the adapted SHARE program or receive usual care. You will attend sessions and do activities with your care partner.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- African American dyads (both the caregivers and the care-recipient, an individual with an early-stage memory impairing condition (e.g., Alzheimer's...
- Care-recipient lives at home.
- The caregiver (CG) and/or the person with dementia (PWD), or symptoms of memory loss must identify as African American.
- PWD must be at least 50 years old and CGs 18 or older,
- Ability to speak and read English,
You likely can't join if
- A mental health condition (e.g., schizophrenia, bipolar disorder, major depression)
- A traumatic brain injury
- Intellectual or developmental disability
- Individuals experiencing extreme difficulty adjusting and coping to the diagnosis Individuals living in an institutional setting
See the full eligibility criteria
- African American dyads (both the caregivers and the care-recipient, an individual with an early-stage memory impairing condition (e.g., Alzheimer's disease, vascular dementia, cognitive impairment, etc.)
- Care-recipient lives at home.
- The caregiver (CG) and/or the person with dementia (PWD), or symptoms of memory loss must identify as African American.
- PWD must be at least 50 years old and CGs 18 or older,
- Ability to speak and read English,
- Experiencing signs and symptoms of mild to moderate dementia through family caregiver report on the Dementia Severity Rating Scale and meeting the National Institute on Aging and the Alzheimer's Association clinical...
- A mental health condition (e.g., schizophrenia, bipolar disorder, major depression)
- A traumatic brain injury
- Intellectual or developmental disability
- Individuals experiencing extreme difficulty adjusting and coping to the diagnosis Individuals living in an institutional setting
The study team makes the final eligibility decision.
Where it is enrolling
- Cleveland, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Cleveland, Ohio, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.